Jean-Pierre Bizzari Net Worth & Insider Trades
Jean-Pierre Bizzari - Director, Halozyme Therapeutics, Inc
What is Jean-Pierre Bizzari's Net Worth?
The current estimated net worth of Halozyme Therapeutics, Inc's Director, Jean-Pierre Bizzari, is estimated to be about $4.89M . Jean-Pierre Bizzari owns about 52,544 units of Halozyme Therapeutics, Inc common stock. In the last 7 years at Halozyme Therapeutics, Inc, Jean-Pierre Bizzari has sold an estimated value of $1.44M worth.
What is Jean-Pierre Bizzari's Past Insider Trading?
Jean-Pierre Bizzari's largest sale order was 35,000 units , worth over $1.44M on August 25, 2021. In total, Jean-Pierre Bizzari has made about 10 transactions over 7 years of their time at Halozyme Therapeutics, Inc. Jean-Pierre Bizzari usually trades in May, with the busiest year in 2015 and 2021.
Jean-Pierre Bizzari
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Jean-Pierre Bizzari's' Mailing Address?
- Mailing address is 235 Laurel Ln Haverfold PA 19041 PA
Halozyme Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Helen I. Torley | 2020 | $791,440 | - | $2,500,018 | $2,500,001 | $712,270 | $15,147 | $6,518,876 |
| Helen I. Torley | 2019 | $761,000 | - | $2,184,130 | $2,184,128 | $712,296 | $15,572 | $5,857,126 |
| Helen I. Torley | 2018 | $725,000 | - | $2,115,640 | $2,115,631 | $831,665 | $11,733 | $5,799,669 |
| Elaine D. Sun | 2020 | $395,833 | $150,000 | $1,500,269 | $1,000,008 | $180,352 | $133,399 | $3,359,861 |
| Laurie D. Stelzer | 2020 | $93,225 | - | - | - | - | $77,996 | $171,221 |
| Laurie D. Stelzer | 2019 | $495,000 | $2,500 | $750,016 | $750,005 | $231,660 | $16,939 | $2,246,120 |
| Laurie D. Stelzer | 2018 | $470,000 | - | $575,018 | $575,009 | $323,489 | $9,409 | $1,952,925 |
| Masaru Matsuda | 2020 | $440,000 | $50,000 | $500,019 | $500,008 | $203,940 | $13,901 | $1,707,868 |
| Michael J. LaBarre | 2020 | $475,000 | - | $650,009 | $650,007 | $220,163 | $15,018 | $2,010,197 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm
What are Halozyme Therapeutics, Inc's Past Insider Trades?
Halozyme Therapeutics, Inc's most recent insider trade came on March 9, 2023 by Helen Torley who sold 30,000 units worth $1.31M . In the last 16 years, insiders at Halozyme Therapeutics, Inc have sold an estimated value of $148.21M and bought an estimated value of $83.48M worth of shares. Insider trading is most common in February, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO, Gregory Ian Frost, CEO, and Randal J Kirk .
HALOZYME THERAPEUTICS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||